These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 25048360)

  • 1. On the correlation between the structure of lyotropic carriers and the delivery profiles of two common NSAIDs.
    Cohen-Avrahami M; Shames AI; Ottaviani MF; Aserin A; Garti N
    Colloids Surf B Biointerfaces; 2014 Oct; 122():231-240. PubMed ID: 25048360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV-TAT enhances the transdermal delivery of NSAID drugs from liquid crystalline mesophases.
    Cohen-Avrahami M; Shames AI; Ottaviani MF; Aserin A; Garti N
    J Phys Chem B; 2014 Jun; 118(23):6277-87. PubMed ID: 24798650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of dendrimer generations on the structure of Q(G) LLC mesophase and drug release.
    Bitan-Cherbakovsky L; Aserin A; Garti N
    Colloids Surf B Biointerfaces; 2014 Oct; 122():30-37. PubMed ID: 25016542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penetratin-induced transdermal delivery from H(II) mesophases of sodium diclofenac.
    Cohen-Avrahami M; Libster D; Aserin A; Garti N
    J Control Release; 2012 May; 159(3):419-28. PubMed ID: 22306174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural effects of insulin-loading into HII mesophases monitored by electron paramagnetic resonance (EPR), small angle X-ray spectroscopy (SAXS), and attenuated total reflection Fourier transform spectroscopy (ATR-FTIR).
    Mishraki T; Ottaviani MF; Shames AI; Aserin A; Garti N
    J Phys Chem B; 2011 Jun; 115(25):8054-62. PubMed ID: 21591776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural characterization of lyotropic liquid crystals containing a dendrimer for solubilization and release of gallic acid.
    Bitan-Cherbakovsky L; Aserin A; Garti N
    Colloids Surf B Biointerfaces; 2013 Dec; 112():87-95. PubMed ID: 23973908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H(II) mesophase and peptide cell-penetrating enhancers for improved transdermal delivery of sodium diclofenac.
    Cohen-Avrahami M; Aserin A; Garti N
    Colloids Surf B Biointerfaces; 2010 Jun; 77(2):131-8. PubMed ID: 20189781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium diclofenac and cell-penetrating peptides embedded in H(II) mesophases: physical characterization and delivery.
    Cohen-Avrahami M; Libster D; Aserin A; Garti N
    J Phys Chem B; 2011 Sep; 115(34):10189-97. PubMed ID: 21749044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro permeation of diclofenac salts from lyotropic liquid crystalline systems.
    Yariv D; Efrat R; Libster D; Aserin A; Garti N
    Colloids Surf B Biointerfaces; 2010 Jul; 78(2):185-92. PubMed ID: 20363601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversed hexagonal lyotropic liquid-crystal and open-shell glycodendrimers as potential vehicles for sustained release of sodium diclofenac.
    Bitan-Cherbakovsky L; Libster D; Appelhans D; Voit B; Aserin A; Garti N
    J Phys Chem B; 2014 Apr; 118(14):4016-24. PubMed ID: 24617448
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On structural transitions in a discontinuous micellar cubic phase loaded with sodium diclofenac.
    Efrat R; Aserin A; Garti N
    J Colloid Interface Sci; 2008 May; 321(1):166-76. PubMed ID: 18279886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of sodium diclofenac loads on mesophase components and structure.
    Efrat R; Shalev DE; Hoffman RE; Aserin A; Garti N
    Langmuir; 2008 Jul; 24(14):7590-5. PubMed ID: 18547072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solubilization of vitamin E into H(II) LLC mesophase in the presence and in the absence of vitamin C.
    Bitan-Cherbakovsky L; Yuli-Amar I; Aserin A; Garti N
    Langmuir; 2010 Mar; 26(5):3648-53. PubMed ID: 20175578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Solubilization of gabapentin into HII mesophases.
    Achrai B; Libster D; Aserin A; Garti N
    J Phys Chem B; 2011 Feb; 115(5):825-35. PubMed ID: 21182317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transitions induced by solubilized fat into reverse hexagonal mesophases.
    Amar-Yuli I; Garti N
    Colloids Surf B Biointerfaces; 2005 Jun; 43(2):72-82. PubMed ID: 15921902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lyotropic Cubic Phases for Drug Delivery: Diffusion and Sustained Release from the Mesophase Evaluated by Electrochemical Methods.
    Nazaruk E; Miszta P; Filipek S; Górecka E; Landau EM; Bilewicz R
    Langmuir; 2015 Nov; 31(46):12753-61. PubMed ID: 26513537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterogeneous micellar solubilization within lyotropic liquid crystals interfaces.
    Goldmünz EY; Aserin A; Ottaviani MF; Shames AI; Garti N
    J Colloid Interface Sci; 2024 Oct; 672():552-563. PubMed ID: 38852356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incorporating a Tetrapeptide into Lyotropic Direct Hexagonal Mesophase.
    Selivanova NM; Gubaidullin AT; Galyametdinov YG
    J Phys Chem B; 2020 Apr; 124(13):2715-2722. PubMed ID: 32207304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluating the link between self-assembled mesophase structure and drug release.
    Phan S; Fong WK; Kirby N; Hanley T; Boyd BJ
    Int J Pharm; 2011 Dec; 421(1):176-82. PubMed ID: 21963475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lyotropic liquid crystal mesophases as transdermal delivery systems for lipophilic drugs: A comparative study.
    de Araujo GRS; Azevedo Lima OV; Barreto Neujahr JP; Matos SS; de Souza TA; Dos Santos AM; Chorilli M; de Souza Araujo AA; Duarte MC; da Cunha Gonsalves JKM; de Souza Nunes R; Dos Santos MRV; Vitorino Sarmento VH; Moreira Lira AA
    Int J Pharm; 2023 Apr; 636():122853. PubMed ID: 36931537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.